Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vomiting × fosaprepitant × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2 Genitourinary 2 Thoracic 1 Sarcoma 1 Head & Neck 1 Dermatologic 1 Breast 1

Conditions

Vomiting 1 Melanoma 1 Carcinoma, Renal Cell 1

Interventions

Aprepitant 3 Ondansetron 2 Dexamethasone 2 Calcium Dobesilate 2 fosaprepitant 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 Sugars 1 Palonosetron 1 Immunoenzyme Techniques 1 Granisetron 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01874119 2018-06-07

HDIL2/Emend

St. Louis University

Phase 2 Terminated

13 enrolled 7 charts

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡